BioCanRx Rolling Open Call for Proposals- NCE


Biotherapeutics for Cancer Treatment

For More Information

For more information, please go to the sponsor website.


BioCanRx is a new Network of Centres of Excellence with a mandate to accelerate Canada's most promising biologically based cancer treatments (immunotherapies and biotherapies) into clinical trials. BioCanRx funds late-stage research that demands collaboration among teams from across disciplines, across sectors and across Canada. The aim is to develop biotherapies in parallel and in combination to determine the most effective ways they can combat cancer to improve the quality and length of a person's life. 

We are now accepting letters of intent for the following four research programs:

  • Clinical Trials Program
  • Enabling Studies Program
  • Catalyst Program
  • Clinical, Social and Economic Impact Program


Investigators located at Canadian Institutions eligible to receive peer-reviewed Tri council funding

Funding Availability

BioCanRx has $25 million in seed funding from the federal government's Networks of Centres of Excellence Program, and strong support from industry, the provinces and many national charities.

Indirect Costs


Special Notes

LETTER OF INTENT to sponsor directly: November 9, 2016 11:59 pm

INTERNAL DEADLINE If Invited to Office of Research: 1 week prior to external deadline

Please submit your application/proposal along with an OR5 form to

EXTERNAL DEADLINE If Invited to sponsor directly: communicated by sponsor

For Questions, please contact

Dr. Kelley Parato, Director, Scientific Affairs:
Dr. John Bell. Scientific Director:

Office of Research

Ornella McCarron, Grants Officer
Office of Research Services
519-824-4120 x52832

Alert Classifications
Funding Opportunities and Sponsor News

Health and Life Sciences
Social Sciences